Blanca Bernard-Davila1, A Corina Aycinena2, John Richardson1, Ann Ogden Gaffney3, Pam Koch4, Isobel Contento4, Christine Sardo Molmenti5, Maria Alvarez6, Dawn Hershman7, Heather Greenlee5. 1. Department of Epidemiology, Mailman School of Public Health, Columbia University Medical Center, New York, NY. 2. Department of Epidemiology, Mailman School of Public Health, Columbia University Medical Center, New York, NY ; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY ; Department of Health and Behavior Studies, Teachers College, Columbia University, New York, NY; Columbia University, New York, NY. 3. Cook For Your Life, New York, NY. 4. Department of Health and Behavior Studies, Teachers College, Columbia University, New York, NY; Columbia University, New York, NY. 5. Department of Epidemiology, Mailman School of Public Health, Columbia University Medical Center, New York, NY ; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY. 6. Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY. 7. Department of Epidemiology, Mailman School of Public Health, Columbia University Medical Center, New York, NY ; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY ; Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY.
Abstract
PURPOSE: The purpose of this study was to understand factors related to recruitment to behavioral intervention trials among Spanish-speaking urban Hispanic breast cancer (BC) survivors. METHODS:Potentially eligible Hispanic BC survivors were recruited from the Columbia University Breast Oncology Clinic, signed informed consent, and completed a screening interview on demographics, medical history, acculturation (Short Acculturation Scale for Hispanics), quality of life (QOL), and perceived benefits/risks of research participation. Trial eligibility criteria included stage 0-III BC, completion of adjuvant treatment, Hispanic, fluency in Spanish, willing to be randomized to active arm (9-session in-person culturally-based ¡Cocinar para su salud! dietary modification program) or control arm (written materials). We compared characteristics between eligible women who did and did not enroll in the trial. RESULTS:102 women completed the screening interview and were eligible to participate. Overall mean age was 57.3 ± 9.5 years, mean time since diagnosis was 3.4 ± 2.1 years, 71% reported annual household income <$15,000 and mean acculturation index score was 1.6 ± 0.6 (scale 1-5, low-high). Of the 102 women, 70 enrolled and 32 declined participation. Reasons stated for non-participation included lack of interest in dietary change, illness, and work constraints. Compared to women who enrolled, women who did not enroll were less likely to be employed (P=0.03) and more likely to only read/speak Spanish (P=0.02). Compared to women who enrolled, non-enrollers were more likely to state that research is costly to participants (P=0.03). CONCLUSION: Lower participation was associated with unemployment, monolingualism, and the perception that research is costly to participants. Future behavioral intervention trials among minority BC survivors need to account for these and other factors that may be related to trial participation.
RCT Entities:
PURPOSE: The purpose of this study was to understand factors related to recruitment to behavioral intervention trials among Spanish-speaking urban Hispanic breast cancer (BC) survivors. METHODS: Potentially eligible Hispanic BC survivors were recruited from the Columbia University Breast Oncology Clinic, signed informed consent, and completed a screening interview on demographics, medical history, acculturation (Short Acculturation Scale for Hispanics), quality of life (QOL), and perceived benefits/risks of research participation. Trial eligibility criteria included stage 0-III BC, completion of adjuvant treatment, Hispanic, fluency in Spanish, willing to be randomized to active arm (9-session in-person culturally-based ¡Cocinar para su salud! dietary modification program) or control arm (written materials). We compared characteristics between eligible women who did and did not enroll in the trial. RESULTS: 102 women completed the screening interview and were eligible to participate. Overall mean age was 57.3 ± 9.5 years, mean time since diagnosis was 3.4 ± 2.1 years, 71% reported annual household income <$15,000 and mean acculturation index score was 1.6 ± 0.6 (scale 1-5, low-high). Of the 102 women, 70 enrolled and 32 declined participation. Reasons stated for non-participation included lack of interest in dietary change, illness, and work constraints. Compared to women who enrolled, women who did not enroll were less likely to be employed (P=0.03) and more likely to only read/speak Spanish (P=0.02). Compared to women who enrolled, non-enrollers were more likely to state that research is costly to participants (P=0.03). CONCLUSION: Lower participation was associated with unemployment, monolingualism, and the perception that research is costly to participants. Future behavioral intervention trials among minority BC survivors need to account for these and other factors that may be related to trial participation.
Authors: Anjali S Advani; Benjamin Atkeson; Carrie L Brown; Bercedis L Peterson; Laura Fish; Jeffrey L Johnson; Jon P Gockerman; Marc Gautier Journal: Cancer Date: 2003-03-15 Impact factor: 6.860
Authors: Warren B Sateren; Edward L Trimble; Jeffrey Abrams; Otis Brawley; Nancy Breen; Leslie Ford; Mary McCabe; Richard Kaplan; Malcolm Smith; Richard Ungerleider; Michaele C Christian Journal: J Clin Oncol Date: 2002-04-15 Impact factor: 44.544
Authors: R M Chamberlain; K A Winter; S Vijayakumar; A T Porter; M Roach; O Streeter; J D Cox; M L Bondy Journal: Int J Radiat Oncol Biol Phys Date: 1998-01-01 Impact factor: 7.038
Authors: Ruth E Patterson; Shirley W Flatt; Nazmus Saquib; Cheryl L Rock; Bette J Caan; Barbara A Parker; Gail A Laughlin; Kirsten Erickson; Cynthia A Thomson; Wayne A Bardwell; Richard A Hajek; John P Pierce Journal: Breast Cancer Res Treat Date: 2010-01-14 Impact factor: 4.872
Authors: Sharon R Sears; Annette L Stanton; Lorna Kwan; Janice L Krupnick; Julia H Rowland; Beth E Meyerowitz; Patricia A Ganz Journal: Cancer Epidemiol Biomarkers Prev Date: 2003-10 Impact factor: 4.254
Authors: Raegan W Durant; Jennifer A Wenzel; Isabel C Scarinci; Debora A Paterniti; Mona N Fouad; Thelma C Hurd; Michelle Y Martin Journal: Cancer Date: 2014-04-01 Impact factor: 6.860
Authors: Isobel Contento; Rachel Paul; Amanda M Marin-Chollom; Ann Ogden Gaffney; Jhack Sepulveda; Naxielly Dominguez; Heewon Gray; Anne M Haase; Dawn L Hershman; Pamela Koch; Heather Greenlee Journal: Cancer Control Date: 2022 Jan-Dec Impact factor: 2.339
Authors: Heather Greenlee; Ann Ogden Gaffney; A Corina Aycinena; Pam Koch; Isobel Contento; Wahida Karmally; John M Richardson; Zaixing Shi; Emerson Lim; Wei-Yann Tsai; Regina M Santella; William S Blaner; Robin D Clugston; Serge Cremers; Susan Pollak; Iryna Sirosh; Katherine D Crew; Matthew Maurer; Kevin Kalinsky; Dawn L Hershman Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-07-26 Impact factor: 4.254
Authors: Steven S Coughlin; Valerie Williams; Nicole Moore; Deborah Bowen; Judith Anglin; Nadine Mansur; Gianluca De Leo Journal: J Cancer Treatment Diagn Date: 2018-06-06
Authors: Ilaria Durosini; Lucrezia Savioni; Stefano Triberti; Paolo Guiddi; Gabriella Pravettoni Journal: Int J Environ Res Public Health Date: 2021-01-22 Impact factor: 3.390
Authors: Elizabeth J Siembida; Holli A Loomans-Kropp; Neha Trivedi; Ann O'Mara; Lillian Sung; Irene Tami-Maury; David R Freyer; Michael Roth Journal: Cancer Date: 2019-12-23 Impact factor: 6.921
Authors: Joseph M Unger; Dawn L Hershman; Cathee Till; Lori M Minasian; Raymond U Osarogiagbon; Mark E Fleury; Riha Vaidya Journal: J Natl Cancer Inst Date: 2021-03-01 Impact factor: 13.506
Authors: Tracy E Crane; Terry A Badger; Patrick O'Connor; Chris Segrin; Alexis Alvarez; Sarah J Freylersythe; Irlena Penaloza; Thaddeus W W Pace; Alla Sikorskii Journal: J Cancer Surviv Date: 2020-11-10 Impact factor: 4.442